Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Max Bio Strategy
Killingworth, Connecticut, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Max Bio Strategy was a small private life sciences consulting company organized as Max Bio Strategy LLC in Connecticut. Available evidence indicates it provided biopharmaceutical strategy, business development, portfolio, licensing, and investment-related consulting rather than operating as a drug developer with its own therapeutic pipeline. Public references to the firm are limited and mostly appear in executive biographies, particularly those of Amanda Hayward, who is described as having served as President of Max Bio Strategy. Connecticut business-directory records indicate the entity was formed in 2016 and is now dissolved.
- Industry
- Consulting
Beyond the preview
Go deeper on Max Bio Strategy.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Max Bio Strategy.